[1]
Jumayev , M. 2026. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. Journal of Science and Innovative Research Studies. 1, 2 (Feb. 2026), 101–105. DOI:https://doi.org/10.5281/zenodo.18792159.